NFKB1 and COVID-19: It has been previously reported that resistin levels were higher in patients suffering COVID-19 [28]; it is also known that resistin enhances the NF-kB transcription factors leading to higher expression of pro-inflammatory cytokines and cytokine storms in COVID-19 [29].